TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial(RCT)of Patient, Caregiver and Physician Communication Coaching in Advanced Cancer
Brief Summary: The purpose of this study is to determine whether a combined intervention for patients, caregivers and oncologists improves communication, quality of life, and quality of care.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Communication training and coaching | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Communication training and coaching; Assigned to Arm(s): Intervention
B: Arm Label: Shared decision-making program; Type: EXPERIMENTAL; Interventions: Other: Shared decision-making program | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Intervention Type: OTHER; Name: Shared decision-making program; Assigned to Arm(s): Shared decision-making program | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual care
C: Arm Label: communication lecture; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: communication lecture | Arm Label: lecture plus CD-ROM; Type: EXPERIMENTAL; Interventions: Behavioral: lecture plus CD-ROM | Intervention Type: BEHAVIORAL; Name: communication lecture; Assigned to Arm(s): communication lecture | Intervention Type: BEHAVIORAL; Name: lecture plus CD-ROM; Assigned to Arm(s): lecture plus CD-ROM
D: Arm Label: Nueva Vida Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Nueva Vida Intervention | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Nueva Vida Intervention; Assigned to Arm(s): Nueva Vida Intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial(RCT)of Patient, Caregiver and Physician Communication Coaching in Advanced Cancer
Brief Summary: The purpose of this study is to determine whether a combined intervention for patients, caregivers and oncologists improves communication, quality of life, and quality of care.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Communication training and coaching | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Communication training and coaching; Assigned to Arm(s): Intervention
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: You Decide | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Reducing Your Risks in the Crash | Intervention Type: OTHER; Name: You Decide; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Reducing Your Risks in the Crash; Assigned to Arm(s): 2
C: Arm Label: Framingham Risk Score; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Framingham and Genetic Risk Score; Type: ACTIVE_COMPARATOR; Interventions: Other: Genetic Risk Score | Intervention Type: OTHER; Name: Genetic Risk Score; Assigned to Arm(s): Framingham and Genetic Risk Score
D: Arm Label: Decision Aid; Type: EXPERIMENTAL; Interventions: Other: Decision Aid | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Decision Aid; Assigned to Arm(s): Decision Aid

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Burst, Tonic and Sham Spinal Cord Stimulation. A Verification of the Best Treatment Protocol
Brief Summary: Recently a novel stimulation design was developed, called burst stimulation. In a non-placebo controlled pilot study burst stimulation seemed superior to tonic stimulation over a period extending more than 2 years, and even though an incidental finding, this design seemed capable of suppressing pain without mandatory induction of paresthesias. This permits for the first time to scientifically prove that spinal cord stimulation is better than placebo stimulation. A study was therefore initiated to find out whether spinal cord stimulation is indeed capable of suppressing neuropathic limb pain in a placebo controlled way.


Options:
A: Arm Label: Early off-stimulation (group B); Type: OTHER; Interventions: Device: Spinal Cord Stimultion (SCS), Device: Spinal cord nerve stimulation | Arm Label: Early on-stimulation (group A); Type: OTHER; Interventions: Device: Spinal Cord Stimultion (SCS), Device: Spinal cord nerve stimulation | Intervention Type: DEVICE; Name: Spinal Cord Stimultion (SCS); Assigned to Arm(s): Early off-stimulation (group B), Early on-stimulation (group A) | Intervention Type: DEVICE; Name: Spinal cord nerve stimulation; Assigned to Arm(s): Early off-stimulation (group B), Early on-stimulation (group A)
B: Arm Label: Tonic; Type: EXPERIMENTAL; Interventions: Procedure: dorsal column stimulator | Arm Label: Sham; Type: EXPERIMENTAL; Interventions: Procedure: dorsal column stimulator | Arm Label: burst; Type: EXPERIMENTAL; Interventions: Procedure: dorsal column stimulator | Intervention Type: PROCEDURE; Name: dorsal column stimulator; Assigned to Arm(s): Sham, Tonic, burst
C: Intervention Type: DRUG; Name: pregabalin; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: Pregabalin; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Burst, Tonic and Sham Spinal Cord Stimulation. A Verification of the Best Treatment Protocol
Brief Summary: Recently a novel stimulation design was developed, called burst stimulation. In a non-placebo controlled pilot study burst stimulation seemed superior to tonic stimulation over a period extending more than 2 years, and even though an incidental finding, this design seemed capable of suppressing pain without mandatory induction of paresthesias. This permits for the first time to scientifically prove that spinal cord stimulation is better than placebo stimulation. A study was therefore initiated to find out whether spinal cord stimulation is indeed capable of suppressing neuropathic limb pain in a placebo controlled way.


Options:
A: Arm Label: Tonic; Type: EXPERIMENTAL; Interventions: Procedure: dorsal column stimulator | Arm Label: Sham; Type: EXPERIMENTAL; Interventions: Procedure: dorsal column stimulator | Arm Label: burst; Type: EXPERIMENTAL; Interventions: Procedure: dorsal column stimulator | Intervention Type: PROCEDURE; Name: dorsal column stimulator; Assigned to Arm(s): Sham, Tonic, burst
B: Arm Label: EES on; Type: EXPERIMENTAL; Interventions: Device: EES on | Arm Label: EES off; Type: PLACEBO_COMPARATOR; Interventions: Device: EES off | Intervention Type: DEVICE; Name: EES on; Assigned to Arm(s): EES on | Intervention Type: DEVICE; Name: EES off; Assigned to Arm(s): EES off
C: Arm Label: CMM; Type: OTHER; Interventions: Other: CMM | Arm Label: HF10 + CMM; Type: ACTIVE_COMPARATOR; Interventions: Device: HF10 Therapy, Other: CMM | Intervention Type: DEVICE; Name: HF10 Therapy; Assigned to Arm(s): HF10 + CMM | Intervention Type: OTHER; Name: CMM; Assigned to Arm(s): CMM, HF10 + CMM
D: Arm Label: HF10 therapy plus CMM; Type: ACTIVE_COMPARATOR; Interventions: Device: Senza HF10 Therapy | Arm Label: CMM Alone; Type: OTHER; Interventions: Other: CMM | Intervention Type: DEVICE; Name: Senza HF10 Therapy; Assigned to Arm(s): HF10 therapy plus CMM | Intervention Type: OTHER; Name: CMM; Assigned to Arm(s): CMM Alone

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Burst, Tonic and Sham Spinal Cord Stimulation. A Verification of the Best Treatment Protocol
Brief Summary: Recently a novel stimulation design was developed, called burst stimulation. In a non-placebo controlled pilot study burst stimulation seemed superior to tonic stimulation over a period extending more than 2 years, and even though an incidental finding, this design seemed capable of suppressing pain without mandatory induction of paresthesias. This permits for the first time to scientifically prove that spinal cord stimulation is better than placebo stimulation. A study was therefore initiated to find out whether spinal cord stimulation is indeed capable of suppressing neuropathic limb pain in a placebo controlled way.


Options:
A: Arm Label: SHAM; Type: SHAM_COMPARATOR; Interventions: Device: Spinal cord stimulation | Arm Label: High Density Stimulation; Type: EXPERIMENTAL; Interventions: Device: Spinal cord stimulation | Arm Label: Conventional stimulation; Type: ACTIVE_COMPARATOR; Interventions: Device: Spinal cord stimulation | Intervention Type: DEVICE; Name: Spinal cord stimulation; Assigned to Arm(s): Conventional stimulation, High Density Stimulation, SHAM
B: Arm Label: Early off-stimulation (group B); Type: OTHER; Interventions: Device: Spinal Cord Stimultion (SCS), Device: Spinal cord nerve stimulation | Arm Label: Early on-stimulation (group A); Type: OTHER; Interventions: Device: Spinal Cord Stimultion (SCS), Device: Spinal cord nerve stimulation | Intervention Type: DEVICE; Name: Spinal Cord Stimultion (SCS); Assigned to Arm(s): Early off-stimulation (group B), Early on-stimulation (group A) | Intervention Type: DEVICE; Name: Spinal cord nerve stimulation; Assigned to Arm(s): Early off-stimulation (group B), Early on-stimulation (group A)
C: Arm Label: Tonic; Type: EXPERIMENTAL; Interventions: Procedure: dorsal column stimulator | Arm Label: Sham; Type: EXPERIMENTAL; Interventions: Procedure: dorsal column stimulator | Arm Label: burst; Type: EXPERIMENTAL; Interventions: Procedure: dorsal column stimulator | Intervention Type: PROCEDURE; Name: dorsal column stimulator; Assigned to Arm(s): Sham, Tonic, burst
D: Arm Label: Spinal Cord Stimulation; Type: EXPERIMENTAL; Interventions: Procedure: Spinal Cord Stimulation | Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Spinal Cord Stimulation; Assigned to Arm(s): Spinal Cord Stimulation

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Detection and Intervention on Mild/Moderate Chronic Obstructive Pulmonary Disease by Traditional Chinese Medicine Treatment and Application
Brief Summary: The purpose of this study is evaluate the effects and safety of Traditional Chinese medicine for prevention and management of mild/moderate chronic obstructive pulmonary disease (COPD).


Options:
A: Arm Label: traditional chinese medicine; Type: EXPERIMENTAL; Interventions: Drug: Traditional Chinese Medicine | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo chinese medicine | Intervention Type: DRUG; Name: Traditional Chinese Medicine; Assigned to Arm(s): traditional chinese medicine | Intervention Type: DRUG; Name: placebo chinese medicine; Assigned to Arm(s): placebo
B: Arm Label: ES; Type: ACTIVE_COMPARATOR; Interventions: Device: Electrostimulation | Arm Label: Sham ES; Type: PLACEBO_COMPARATOR; Interventions: Device: Sham stimulation | Intervention Type: DEVICE; Name: Electrostimulation; Assigned to Arm(s): ES | Intervention Type: DEVICE; Name: Sham stimulation; Assigned to Arm(s): Sham ES
C: Arm Label: Tool + Self-management Support Program; Type: EXPERIMENTAL; Interventions: Device: Tool, Behavioral: Self-management Support Program | Arm Label: Self- management Support Program; Type: EXPERIMENTAL; Interventions: Behavioral: Self-management Support Program | Arm Label: Care as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Tool; Assigned to Arm(s): Tool + Self-management Support Program | Intervention Type: BEHAVIORAL; Name: Self-management Support Program; Assigned to Arm(s): Self- management Support Program, Tool + Self-management Support Program
D: Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo to tiotropium + olodaterol | Arm Label: tiotropium + olodaterol high dose with BM; Type: EXPERIMENTAL; Interventions: Drug: tiotropium +olodaterol | Arm Label: tiotropium; Type: ACTIVE_COMPARATOR; Interventions: Drug: tiotropium | Arm Label: tiotropium + olodaterol with exercise training and BM; Type: EXPERIMENTAL; Interventions: Drug: tiotropium+olodaterol | Intervention Type: DRUG; Name: placebo to tiotropium + olodaterol; Assigned to Arm(s): placebo | Intervention Type: DRUG; Name: tiotropium+olodaterol; Assigned to Arm(s): tiotropium + olodaterol with exercise training and BM | Intervention Type: DRUG; Name: tiotropium +olodaterol; Assigned to Arm(s): tiotropium + olodaterol high dose with BM | Intervention Type: DRUG; Name: tiotropium; Assigned to Arm(s): tiotropium

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Detection and Intervention on Mild/Moderate Chronic Obstructive Pulmonary Disease by Traditional Chinese Medicine Treatment and Application
Brief Summary: The purpose of this study is evaluate the effects and safety of Traditional Chinese medicine for prevention and management of mild/moderate chronic obstructive pulmonary disease (COPD).


Options:
A: Arm Label: Urban training Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Urban training | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Urban training; Assigned to Arm(s): Urban training Intervention
B: Arm Label: traditional chinese medicine; Type: EXPERIMENTAL; Interventions: Drug: Traditional Chinese Medicine | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo chinese medicine | Intervention Type: DRUG; Name: Traditional Chinese Medicine; Assigned to Arm(s): traditional chinese medicine | Intervention Type: DRUG; Name: placebo chinese medicine; Assigned to Arm(s): placebo
C: Arm Label: Control group (Group A); Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care | Arm Label: Intervention group (Group B); Type: OTHER; Interventions: Other: Home-based telehealth program, Other: Home-based rehabilitation, Other: Usual care | Intervention Type: OTHER; Name: Home-based telehealth program; Assigned to Arm(s): Intervention group (Group B) | Intervention Type: OTHER; Name: Home-based rehabilitation; Assigned to Arm(s): Intervention group (Group B) | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Control group (Group A), Intervention group (Group B)
D: Arm Label: Case Management and Self-Management Education; Type: EXPERIMENTAL; Interventions: Other: Case Management and Self-Management Education | Arm Label: Usual Care; Type: PLACEBO_COMPARATOR; Interventions: Other: Case Management and Self-Management Education | Intervention Type: OTHER; Name: Case Management and Self-Management Education; Assigned to Arm(s): Case Management and Self-Management Education, Usual Care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Identifying and Overcoming Barriers to Diabetes Management in the Elderly: A Cost-effective Intervention Study
Brief Summary: The purpose of this study is to find ways to identify barriers that affect self care in older adult with diabetes and to provide cost effective coping strategies to improve clinical, functional and psychosocial measures.


Options:
A: Arm Label: Geriatric Diabetes Team Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral | Arm Label: Atention Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Behavioral; Assigned to Arm(s): Geriatric Diabetes Team Intervention
B: Arm Label: Group A; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Group B; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Simulated case-based customized learning | Arm Label: Group C; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Simulated case based customized learning + leader feedback | Intervention Type: BEHAVIORAL; Name: Simulated case-based customized learning; Assigned to Arm(s): Group B | Intervention Type: BEHAVIORAL; Name: Simulated case based customized learning + leader feedback; Assigned to Arm(s): Group C
C: Arm Label: Telecare; Type: EXPERIMENTAL; Interventions: Other: Telecare | Arm Label: Conventional therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional therapy | Intervention Type: OTHER; Name: Telecare; Assigned to Arm(s): Telecare | Intervention Type: OTHER; Name: Conventional therapy; Assigned to Arm(s): Conventional therapy
D: Arm Label: Telemedicine; Type: EXPERIMENTAL; Interventions: Procedure: Ophthalmic Telemedicine | Arm Label: Traditional Surveillance; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Ophthalmic Telemedicine; Assigned to Arm(s): Telemedicine

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Identifying and Overcoming Barriers to Diabetes Management in the Elderly: A Cost-effective Intervention Study
Brief Summary: The purpose of this study is to find ways to identify barriers that affect self care in older adult with diabetes and to provide cost effective coping strategies to improve clinical, functional and psychosocial measures.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Breaking Down Barriers | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Breaking Down Barriers | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Breaking Down Barriers | Intervention Type: BEHAVIORAL; Name: Breaking Down Barriers; Assigned to Arm(s): 1, 2, 3
B: Arm Label: Geriatric Diabetes Team Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral | Arm Label: Atention Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Behavioral; Assigned to Arm(s): Geriatric Diabetes Team Intervention
C: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile application for diabetes self-management | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mobile application for diabetes self-management; Assigned to Arm(s): Intervention Group
D: Intervention Type: BEHAVIORAL; Name: Nurse Case Management intervention; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Safety of Gabapentin in Treating Overactive Bladder
Brief Summary: Overactive bladder (OAB) syndrome as defined by International Continence Society is a pathological condition characterized by irritative symptoms: urinary urgency, with or without incontinence, urinary frequency and nocturia. The syndrome often seriously compromises the quality of life of the patients. The etiology of the OAB is considered multifactorial. Neural plasticity of bladder afferent pathways is one of the proposed mechanisms of OAB. The detrusor muscle itself has for many years been the target for drug treatment such as antimuscarinics. However, depression of detrusor contractility, may results in a reduced ability to empty the bladder and lead to some sympathetic adverse effects, which limits the treatment of OAB. Currently the focus of OAB treatment has changed to other bladder structures/mechanisms, such as afferent nerves and urothelial signaling as targets for intervention. C-fiber bladder afferents nerves may be critical for symptom generation in pathologic states such as OAB because these fibers demonstrate remarkable plasticity. Up-regulation of bladder C-fiber afferent nerve function may also play a role in urge incontinence, overactive bladder (OAB) and sensory urgency. The mechanism of Gabapentin's action for neuropathic pain has not been fully elucidated but is appears to have inhibitory activity on afferent C-fibers nerve activity; moreover, several studies had established the safety of Gabapentin in its treatment of different conditions. Due to the proposed mechanism, the investigators suggest that Gabapentin may be a new alternative for treating OAB.


Options:
A: Arm Label: Gabapentin; Type: EXPERIMENTAL; Interventions: Drug: Gabapentin | Arm Label: Solifenacin Succinate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Solifenacin Succinate | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo drugs | Intervention Type: DRUG; Name: Gabapentin; Assigned to Arm(s): Gabapentin | Intervention Type: DRUG; Name: Solifenacin Succinate; Assigned to Arm(s): Solifenacin Succinate | Intervention Type: DRUG; Name: Placebo drugs; Assigned to Arm(s): Placebo
B: Intervention Type: DRUG; Name: Tolterodine ER 4mg QD; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: YM178; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: tolterodine SR, overactive bladder; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Bevacizumab Versus Ranibizumab for Refractory Diabetic Macular Edema
Brief Summary: The purpose of this study is to compare the morphological and visual acuity outcomes associated with 1.5 mg bevacizumab versus 0.5 ranibizumab intravitreal injections for treatment of diabetic macular edema.


Options:
A: Arm Label: Cohort with routine OCT monitoring; Type: N/A; Interventions: N/A | Arm Label: Cohort without routine OCT monitoring; Type: N/A; Interventions: N/A
B: Intervention Type: DRUG; Name: DEX PS DDS®; Assigned to Arm(s): N/A
C: Arm Label: Bevacizumab; Type: EXPERIMENTAL; Interventions: Drug: Bevacizumab | Arm Label: Ranibizumab; Type: EXPERIMENTAL; Interventions: Drug: Ranibizumab | Intervention Type: DRUG; Name: Bevacizumab; Assigned to Arm(s): Bevacizumab | Intervention Type: DRUG; Name: Ranibizumab; Assigned to Arm(s): Ranibizumab
D: Arm Label: Ranibizumab 0.3 mg; Type: EXPERIMENTAL; Interventions: Drug: Ranibizumab | Arm Label: Ranibizumab 0.5 mg; Type: EXPERIMENTAL; Interventions: Drug: Ranibizumab | Arm Label: Sham injection/ranibizumab 0.5 mg; Type: SHAM_COMPARATOR; Interventions: Drug: Sham injection | Intervention Type: DRUG; Name: Ranibizumab; Assigned to Arm(s): Ranibizumab 0.3 mg, Ranibizumab 0.5 mg | Intervention Type: DRUG; Name: Sham injection; Assigned to Arm(s): Sham injection/ranibizumab 0.5 mg

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Bevacizumab Versus Ranibizumab for Refractory Diabetic Macular Edema
Brief Summary: The purpose of this study is to compare the morphological and visual acuity outcomes associated with 1.5 mg bevacizumab versus 0.5 ranibizumab intravitreal injections for treatment of diabetic macular edema.


Options:
A: Intervention Type: DRUG; Name: bevacizumab; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: triamcinolone acetonide; Assigned to Arm(s): N/A
B: Arm Label: Ranibizumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: 0.3 mg intravitreal ranibizumab | Arm Label: Aflibercept; Type: EXPERIMENTAL; Interventions: Drug: 2.0 mg intravitreal aflibercept | Arm Label: Bevacizumab; Type: EXPERIMENTAL; Interventions: Drug: 1.25 mg intravitreal bevacizumab | Intervention Type: DRUG; Name: 2.0 mg intravitreal aflibercept; Assigned to Arm(s): Aflibercept | Intervention Type: DRUG; Name: 1.25 mg intravitreal bevacizumab; Assigned to Arm(s): Bevacizumab | Intervention Type: DRUG; Name: 0.3 mg intravitreal ranibizumab; Assigned to Arm(s): Ranibizumab
C: Arm Label: Sham Control; Type: SHAM_COMPARATOR; Interventions: Drug: Standard of Care | Arm Label: Macugen; Type: EXPERIMENTAL; Interventions: Drug: Macugen | Intervention Type: DRUG; Name: Standard of Care; Assigned to Arm(s): Sham Control | Intervention Type: DRUG; Name: Macugen; Assigned to Arm(s): Macugen
D: Arm Label: Bevacizumab; Type: EXPERIMENTAL; Interventions: Drug: Bevacizumab | Arm Label: Ranibizumab; Type: EXPERIMENTAL; Interventions: Drug: Ranibizumab | Intervention Type: DRUG; Name: Bevacizumab; Assigned to Arm(s): Bevacizumab | Intervention Type: DRUG; Name: Ranibizumab; Assigned to Arm(s): Ranibizumab

Answer: D